ID
9010
Description
E2408 Registration Worksheet (step 2) Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8E95E365-24C3-A131-E040-BB89AD431C79
Link
Keywords
Versions (2)
- 9/19/12 9/19/12 -
- 1/9/15 1/9/15 - Martin Dugas
Uploaded on
January 9, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Lymphoma NCT01216683 Eligibility - E2408 Registration Worksheet (step 2) - 3132466v1.0
No Instruction available.
- StudyEvent: E2408 Registration Worksheet (step 2)
Description
Note: The Ecog Registration Program Uses This Field To Store The Induction Treatment The Patient Was Assigned. Patient Stratification Is Based On This Value.
Description
Note: The Ecog Registration Program Uses This Field To Store The Ecog Patient Id.
Similar models
No Instruction available.
- StudyEvent: E2408 Registration Worksheet (step 2)
C1512698 (UMLS 2011AA ValueDomain)
C25250 (NCI Thesaurus Property)
C0205197 (UMLS 2011AA Property)
C25171 (NCI Thesaurus ObjectClass)
C0013893 (UMLS 2011AA ObjectClass)
C49073 (NCI Thesaurus Property-2)
C1707357 (UMLS 2011AA Property-2)
C1302261 (UMLS CUI-1)
C16960 (NCI Thesaurus ObjectClass)
C25171 (NCI Thesaurus Property)